home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

BioBusiness Network 2005

 
  April 04, 2005  
     
 
WBR, Hotel President Wilson, Geneva
September 20-22, 2005


Greater Availability Of 1-to-1 Meetings And An ‘Easier To Use’ New Website
The number of meeting rooms is being extended to at least 16, and the website is being completely revamped to ensure that you get all the meetings you want with the companies you’ve targeted.


Learn How To Profile Yourself As An Early-Stage Biotech To Attract The Most Viable Sources Of Financing
IPO may seem like years away, but how should you profile yourself to attract private financing, a big pharma partnership or even a merger? Learn from companies that have successfully attracted financing despite having an exclusive preclinical focus!


2 Inspirational Keynote Speakers Already Confirmed
Learn from how to build a commercially sustainable opportunity around your science, and from Christian Chavy, President, EMEA of Actelion, how to manage the risks of developing a pan-European sales force as a biotech. The first two of many cutting-edge case studies to be presented this September!

 
 
Organized by: WBR
Invited Speakers: * Peter Chambré, CEO of Cambridge Antibody Technology
* Christian Chavy, President, EMEA of Actelion
 
Deadline for Abstracts: N/A
 
Registration: Call Rachel Bridgman on +44 (0) 20 7368 9400
E-mail: rachel7@wbr.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.